1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 06 OCTOBER 2014

Cancer Drug News 06 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Oxford BioTherapeutics Instrumental In Several Of Big Pharma's ADC Developments
Industry Brief - Halaven Launches In Australia For MBC Patients
Industry Brief - ERYTECH Reports Positive Phase III Results With Graspa In ALL
Industry Brief - Incyte Earns Milestone Payment Related To Jakavi's Reimbursement In Europe
Industry Trend Analysis - UK's NICE Continues Rejection Trend With Obinutuzumab
Industry Brief - Immunovaccine Provides Update On DPX-Survivac
Industry Trend Analysis - Combinations Key To Pfizer's Immuno-Oncology Success
Industry Brief - Vosaroxin/Cytarabine Phase III Trial Fails To Meet Primary Endpoint
Industry Brief - CleveXel Licenses Two Oncology Patents From SATT Sud Est
Industry Trend Analysis - Blood-Based Diagnostic Opens New Market For Iressa
Industry Trend Analysis - Breakthrough Designation Signals More Positive Future For ARIAD
Industry Brief - Trelstar Six-Month Dosing For PCA Launches In Canada
Industry Brief - FDA Grants ODD To Halozyme's PEGPH20 For PC
Industry Brief - Insys' Pharmaceutical CBD Receives FDA ODD For Glioma
Industry Brief - BMS Reports Multiple Regulatory Milestones For Opdivo In US/EU
Industry Brief - Pharmacyclics/Servier End Pan-HDAC Inhibitor Collaboration
Industry Trend Analysis - Multiple ODDs For CytRx Cover Three Areas Of Unmet Medical Need
Industry Trend Analysis - Genentech Faces Backlash Over Cancer Drug Distribution Changes
Industry Brief - Sorrento/Lee's Pharma Enter Chinese Licensing Agreement For Anti-PD-L1 Antibody
Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory
Industry Brief - KHK Receives Japanese Approval For G-Lasta
Industry Brief - Positive Phase III Data Reported For Anamorelin In NSCLC Patients With Anorexia-Cachexia
Industry Brief - to-BBB Completes Management Team And Changes Name To BBB Therapeutics
Industry Brief - Baxter To Form New Global Innovation/R&D Centre For Biopharmaceuticals Business
Industry Brief - Prima BioMed To Acquire Immutep
Industry Brief - Cancer Conferences - January 2015

Table Of Contents

Cancer Drug News 06 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.